The mouse H-2A region influences the envelope gene structure of tumor- associated murine leukemia viruses

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3973-3979

  Nuckols, J Dean ^a   Thomas, Christopher Y ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE STRUCTURE; GENETIC VARIABILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS MUTANT;

EID: 0031958095     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3973-3979.1998     Document Type: Article

References (49)

1. Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. F. Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647-649.
2. Chattopadhyay, S. K., M. W. Cloyd, D. L. Linemeyer, M. R. Lander, E. Rands, and D. R. Lowy. 1982. Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas. Nature 295:25-31.
3. Cloyd, M. D., J. W. Hartley, and W. P. Rowe. 1980. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia virus. J. Exp. Med. 151:542-549.
4. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:143-164. (Review.)
5. Coffin, J. M., J. P. Stoye, and W. N. Frankel. 1989. Genetics of endogenous murine leukemia viruses. Ann. N. Y. Acad. Sci. 567:39-49.
6. Coppola, M., and C. Thomas. Unpublished data.
7. Coppola, M. A., and C. Y. Thomas. 1990. A host gene regulates the structure of the transmembrane envelope protein of murine leukemia viruses. J. Exp. Med. 171:1739-1752.
8. Coppola, M. A., T. M. Lam, R. R. Strawbridge, and W. R. Green. 1995. Recognition of endogenous ecotropic murine leukemia viruses by anti-AKR/ Gross virus cytotoxic T lymphocytes (CTL). J. Gen. Virol. 76:635-641.
9. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittingboff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, and R. Detels. 1996. Genetic restriction of hiv-1 infection and progression to aids by a deletion allele of the ckr5 structural gene. Science 273:1856-1862.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, I. R. Littman, and N. R Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. DiFronzo, N. L., and C. A. Holland. 1993. A direct demonstration of recombination between an injected virus and endogenous viral sequences, resulting in the generation of mink cell focus-inducing viruses in AKR mice. J. Virol. 67:3763-3770.
12. Dragic, T., V. Litwin, G. P. Allaway, S. P. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and P. J. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
13. Famulari, N. G., D. L. Buchhagen, H. D. Klenk, and E. Fleissner. 1976. Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J. Virol. 20:501-508.
14. Famulari, N. G. 1983. Murine leukemia viruses with recombinant env genes: a discussion of their role in leukemogenesis. Curr. Top. Microbiol. Immunol. 103:75-108.
15. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. ran Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418.
16. Green, N., H. Hiai, J. H. Elder, R. S. Schwartz, R. H. Khiroya, C. Y. Thomas, P. N. Tsichlis, and J. M. Coffin. 1980. Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J. Exp. Med. 152:249-264.
17. Green, W. R. 1986. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation. J. Immunol. 136: 308-312.
18. Hartley, J. W., N. K. Wolford, L. J. Old, and W. P. Rowe. 1977. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. USA 74:789-792.
19. Herr, W., and W. Gilbert 1983. Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice. J. Virol. 46:70-82.
20. Ihle, J. N., J. J. Domotor, Jr., and K. M. Bengali. 1976. Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses. J. Virol. 18:124-131.
21. Jolicoeur, P. 1979. The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 86:67-122. (Review.)
22. Lawrenz-Smith, S. C., A. C. Massey, D. J. Innes, and C. Y. Thomas. 1994. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice. J. Virol. 68:5174-5183.
23. Li, J. P., and D. Baltimore. 1991. Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol. 65:2408-2414.
24. 1-resistant oligonucleotides encoding p15E and the U3 region of the long terminal repeat distinguish two biological classes of mink cell focus-forming type C viruses of inbred mice. J. Virol. 45:275-290.
25. Miyazawa, M., J. Nishio, K. Wehrly, and B. Chesebro. 1992. Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia. J. Immunol. 148:644-647.
26. Monaco, J. J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250: 1723-1726.
27. Nowinski, R. C., M. G. Brown, T. Doyle, and R. L. Prentice. 1979. Genetic and viral factors influencing the development of spontaneous leukemia in AKR mice. Virology 96:186-204.
28. Nuckols, J. D., and C. Y. Thomas. Unpublished data.
29. Rommelaere, J., D. V. Faller, and N. Hopkins. 1978. Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses. Proc. Natl. Acad. Sci. USA 75: 495.
30. Stoye, J. P., and J. M. Coffin. 1987. The four classes of endogenous murine leukemia viruses; structural relationships and potential for recombination. J. Virol. 61:2659-2669.
31. Teich, N. 1982. Taxonomy of retroviruses, p. 25-208. In R. Weiss, H. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32. Thiel, H. J., H. Schwarz, P. Fischinger, D. Bolognesi, and W. Scheafer. 1987. Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 84:5893-5897.
33. Thomas, C. Y. 1986. AKR ecotropic murine leukemia virus SL3-3 forms envelope gene recombinants in vivo. J. Virol. 59:23-30.
34. Thomas, C. Y., B. J. Boykin, N. G. Famulari, and M. A. Coppola. 1986. Association of recombinant murine leukemia viruses of the class II genotype with spontaneous lymphomas in CWD mice. J. Virol. 58:314-323.
35. Thomas, C. Y., M. A. Coppola, C. A. Holland, and A. C. Massey. 1990. Oncogenicity and U3 region sequences of class II recombinant MuLVs of CWD mice. Virology 176:166-177.
36. Thomas, C. Y., M. A. Coppola, J. D. Nuckols, S. C. Lawrenz-Smith, and A. C. Massey. 1993. An increase in disease latency is associated with a host-dependent selection for recombinant MuLVs with substitutions in the P15E (TM) gene. J. Virol. 67:294-304.
37. Thomas, C. Y., R. Khiroya, R. S. Schwartz, and J. M. Coffin. 1984. Role of recombinant ecotropic and polytropic viruses in the development of spontaneous thymic lymphomas in HRS/J mice. J. Virol. 50:397-407.
38. Thomas, C. Y., J. D. Nuckols, C. F. Murphy, and D. J. Innes. 1993. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus. Virology 193:1013-1017.
39. Thomas, C. Y., J. S. Roberts, and V. K. Buxton. 1988. Mechanism of selection of class II recombinant murine leukemia viruses in the highly leukemic strain CWD. J. Virol. 62:1158-1166.
40. Trowsdale, J. 1993. Genomic structure and function in the MHC. Trends Genet. 9:117-122.
41. Tsichlis, P. N., and P. A. Lazo. 1991. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171:95-171.
42. Vasmel, W. L., E. J. Sijts, C. J. Leupers, E. A. Matthews, and C. J. Melief. 1989. Primary virus-induced lymphomas evade T-cell immunity by failure to express viral antigens. J. Exp. Med. 169:1233-1254.
43. Vasmel, W. L., M. Zijlstra, T. Radaszkiewicz, C. J. Leupers, R. E. de Goede, and C. J. Melief. 1988. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T-but not late B-cell lymphomas. J. Virol. 62:3156-3166.
44. Vlug, A., C. J. Melief, C. de Bruyne, H. Schoenmakers, and J. L. Molenaar. 1980. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens. J. Natl. Cancer Inst. 64:1191-1198.
45. Zaane, D. V., A. L. Gielkens, W. G. Hesselink, and H. P. Bloemers. 1977. Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag-and env-gene products. Proc. Natl. Acad. Sci. USA 74:1855.
46. Zhou, P., H. Cao, M. Smart, and C. David. 1993. Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (LMP-2). Proc. Natl. Acad. Sci. USA 90:2681-2684.
47. Zhou, X. Z., R. Glas, T. M. Liu, H. G. Ljunggren, and M. Jondal. 1993. Antigen-processing mutant T2 cells present viral-antigen restricted through H-2Kb. Eur. J. Immunol. 23:1802-1808.
48. Zijlstra, M., and C. J. M. Melief. 1986. Virology, genetics and immunology of murine lymphomagenesis. Biochim. Biophys. Acta 865:197-231.
49. Zijlstra, M., R. E. Y. De Goede, H. Schoenmakers, T. Radaszkeiwicz, and C. J. M. Melief. 1984. Ecotropic and dualtropic mink cell focus-inducing murine leukemia viruses can induce a wide spectrum of H-2 controlled lymphoma types. Virology 138:198-211.